of FR940405-1-00071 11 420 432 464 545 648 757 801 814 842 856 899
uniform FR940405-1-00071 1 421
air FR940405-1-00071 14 422 451 480 488 498 518 525 534 571 585 824 901 963 1012
velocities FR940405-1-00071 2 423 452
, FR940405-1-00071 25 424 450 496 540 556 561 574 614 644 657 661 666 727 733 844 869 883 903 916 921 924 929 936 941 973
temperatures FR940405-1-00071 1 425
and FR940405-1-00071 15 426 462 485 549 592 603 646 671 734 826 861 925 956 964 1017
humidities FR940405-1-00071 1 427
in FR940405-1-00071 16 428 446 472 493 500 567 596 611 636 789 806 839 886 896 991 1014
the FR940405-1-00071 31 429 478 486 494 497 501 513 516 523 529 532 575 597 653 669 691 705 731 746 762 774 786 790 799 840 887 897 904 974 992 1015
occupied FR940405-1-00071 3 430 448 502
zone FR940405-1-00071 3 431 449 503
a FR940405-1-00071 9 433 473 568 624 720 768 794 811 984
room FR940405-1-00071 5 434 517 530 570 584
( FR940405-1-00071 4 435 459 482 605
eg FR940405-1-00071 1 436
; FR940405-1-00071 1 437
floor FR940405-1-00071 2 438 443
to FR940405-1-00071 23 439 528 562 619 626 641 663 678 716 730 741 792 822 836 852 876 908 966 982 998 1002 1009 1025
6 FR940405-1-00071 1 440
feet FR940405-1-00071 2 441 456
above FR940405-1-00071 1 442
) FR940405-1-00071 4 444 461 484 607
. FR940405-1-00071 23 445 471 543 566 580 610 630 651 684 719 749 777 779 810 828 838 864 892 895 943 971 994 1028
this FR940405-1-00071 2 447 866
less FR940405-1-00071 2 453 627
than FR940405-1-00071 1 454
50 FR940405-1-00071 1 455
per FR940405-1-00071 1 457
minute FR940405-1-00071 1 458
fpm FR940405-1-00071 1 460
minimization FR940405-1-00071 1 463
temperature FR940405-1-00071 1 465
gradients FR940405-1-00071 1 466
will FR940405-1-00071 1 467
promote FR940405-1-00071 1 468
occupant FR940405-1-00071 1 469
comfort FR940405-1-00071 3 470 579 649
conventional FR940405-1-00071 2 474 637
mixing FR940405-1-00071 2 475 569
system FR940405-1-00071 2 476 573
where FR940405-1-00071 3 477 515 708
supply FR940405-1-00071 2 479 533
diffusers FR940405-1-00071 2 481 535
outlets FR940405-1-00071 1 483
return FR940405-1-00071 1 487
grilles FR940405-1-00071 1 489
are FR940405-1-00071 5 490 582 633 850 949
both FR940405-1-00071 1 491
located FR940405-1-00071 1 492
ceiling FR940405-1-00071 2 495 514
motion FR940405-1-00071 1 499
could FR940405-1-00071 2 504 752
be FR940405-1-00071 5 505 668 753 877 967
characterized FR940405-1-00071 1 506
as FR940405-1-00071 5 507 884 918 931 954
`` FR940405-1-00071 4 508 872 932 937
gentle FR940405-1-00071 1 509
drift FR940405-1-00071 1 510
'' FR940405-1-00071 4 511 875 935 940
toward FR940405-1-00071 1 512
is FR940405-1-00071 15 519 554 577 616 688 693 702 714 725 739 764 798 945 996 1018
then FR940405-1-00071 1 520
mixed FR940405-1-00071 1 521
with FR940405-1-00071 3 522 820 960
conditioned FR940405-1-00071 1 524
being FR940405-1-00071 2 526 765
delivered FR940405-1-00071 1 527
through FR940405-1-00071 1 531
[ FR940405-1-00071 2 536 890
1993 FR940405-1-00071 1 537
ashrae FR940405-1-00071 1 538
handbook FR940405-1-00071 1 539
ch.31 FR940405-1-00071 1 541
] FR940405-1-00071 2 542 894
because FR940405-1-00071 3 544 690 761
natural FR940405-1-00071 1 546
convection FR940405-1-00071 1 547
currents FR940405-1-00071 1 548
thermal FR940405-1-00071 1 550
buoyancy FR940405-1-00071 1 551
forces FR940405-1-00071 1 552
it FR940405-1-00071 2 553 701
common FR940405-1-00071 1 555
especially FR940405-1-00071 1 557
during FR940405-1-00071 1 558
heating FR940405-1-00071 1 559
season FR940405-1-00071 1 560
have FR940405-1-00071 4 563 593 817 979
stagnant FR940405-1-00071 1 564
zones FR940405-1-00071 1 565
distribution FR940405-1-00071 2 572 586
emphasis FR940405-1-00071 1 576
on FR940405-1-00071 3 578 911 1021
there FR940405-1-00071 3 581 615 948
other FR940405-1-00071 2 583 926
schemes FR940405-1-00071 3 587 613 632
which FR940405-1-00071 2 588 724
consider FR940405-1-00071 1 589
contaminant FR940405-1-00071 4 590 679 692 763
control FR940405-1-00071 2 591 717
been FR940405-1-00071 2 594 818
used FR940405-1-00071 2 595 635
industrial FR940405-1-00071 2 598 654
environment FR940405-1-00071 2 599 707
like FR940405-1-00071 2 600 682
displacement FR940405-1-00071 1 601
ventilation FR940405-1-00071 6 602 609 660 687 713 760
unidirectional FR940405-1-00071 1 604
plugflow FR940405-1-00071 1 606
airflow FR940405-1-00071 1 608
these FR940405-1-00071 5 612 631 829 989 1026
an FR940405-1-00071 3 617 755 808
attempt FR940405-1-00071 1 618
move FR940405-1-00071 1 620
contaminants FR940405-1-00071 1 621
directionally FR940405-1-00071 1 622
along FR940405-1-00071 1 623
clean FR940405-1-00071 2 625 628
gradient FR940405-1-00071 1 629
seldom FR940405-1-00071 1 634
hvac FR940405-1-00071 1 638
systems FR940405-1-00071 1 639
due FR940405-1-00071 1 640
their FR940405-1-00071 1 642
cost FR940405-1-00071 1 643
feasibility FR940405-1-00071 1 645
compromise FR940405-1-00071 1 647
issues FR940405-1-00071 1 650
from FR940405-1-00071 3 652 767 832
hygiene FR940405-1-00071 1 655
perspective FR940405-1-00071 1 656
local FR940405-1-00071 2 658 758
exhaust FR940405-1-00071 2 659 759
specific FR940405-1-00071 3 662 686 912
each FR940405-1-00071 1 664
source FR940405-1-00071 3 665 699 770
would FR940405-1-00071 1 667
preferred FR940405-1-00071 1 670
recommended FR940405-1-00071 1 672
method FR940405-1-00071 1 673
for FR940405-1-00071 4 674 804 865 1006
controlling FR940405-1-00071 1 675
occupational FR940405-1-00071 2 676 969
exposures FR940405-1-00071 2 677 718
point FR940405-1-00071 1 680
sources FR940405-1-00071 2 681 1023
ets FR940405-1-00071 3 683 827 843
such FR940405-1-00071 6 685 750 807 917 930 953
effective FR940405-1-00071 1 689
captured FR940405-1-00071 1 694
or FR940405-1-00071 1 695
contained FR940405-1-00071 1 696
at FR940405-1-00071 1 697
its FR940405-1-00071 1 698
before FR940405-1-00071 1 700
dispersed FR940405-1-00071 1 703
into FR940405-1-00071 2 704 773
work FR940405-1-00071 1 706
only FR940405-1-00071 2 709 905
ineffective FR940405-1-00071 1 710
general FR940405-1-00071 2 711 775
dilution FR940405-1-00071 1 712
available FR940405-1-00071 3 715 851 907
designated FR940405-1-00071 2 721 747
smoking FR940405-1-00071 1 722
area FR940405-1-00071 2 723 748
enclosed FR940405-1-00071 1 726
exhausted FR940405-1-00071 2 728 766
directly FR940405-1-00071 1 729
outside FR940405-1-00071 1 732
maintained FR940405-1-00071 1 735
under FR940405-1-00071 1 736
negative FR940405-1-00071 1 737
pressure FR940405-1-00071 1 738
sufficient FR940405-1-00071 1 740
contain FR940405-1-00071 1 742
tobacco FR940405-1-00071 1 743
smoke FR940405-1-00071 1 744
within FR940405-1-00071 1 745
areas FR940405-1-00071 1 751
considered FR940405-1-00071 1 754
application FR940405-1-00071 1 756
confined FR940405-1-00071 1 769
without FR940405-1-00071 1 771
dispersal FR940405-1-00071 1 772
workspace FR940405-1-00071 1 776
iv FR940405-1-00071 1 778
preliminary FR940405-1-00071 1 780
quantitative FR940405-1-00071 3 781 795 985
risk FR940405-1-00071 6 782 796 857 867 986 1004
assessment FR940405-1-00071 5 783 797 809 868 987
a. FR940405-1-00071 1 784
introduction FR940405-1-00071 1 785
determining FR940405-1-00071 1 787
factor FR940405-1-00071 1 788
decision FR940405-1-00071 1 791
perform FR940405-1-00071 1 793
availability FR940405-1-00071 1 800
suitable FR940405-1-00071 1 802
data FR940405-1-00071 5 803 849 906 981 1022
use FR940405-1-00071 1 805
wide FR940405-1-00071 1 812
spectrum FR940405-1-00071 1 813
health FR940405-1-00071 2 815 914
effects FR940405-1-00071 4 816 830 835 915
associated FR940405-1-00071 2 819 959
exposure FR940405-1-00071 1 821
indoor FR940405-1-00071 4 823 900 962 1011
pollutants FR940405-1-00071 2 825 902
range FR940405-1-00071 1 831
acute FR940405-1-00071 2 833 913
irritant FR940405-1-00071 1 834
cancer FR940405-1-00071 2 837 860
case FR940405-1-00071 2 841 898
osha FR940405-1-00071 5 845 870 909 944 995
has FR940405-1-00071 1 846
determined FR940405-1-00071 1 847
that FR940405-1-00071 2 848 947
quantify FR940405-1-00071 1 853
two FR940405-1-00071 1 854
types FR940405-1-00071 1 855
: FR940405-1-00071 1 858
lung FR940405-1-00071 1 859
heart FR940405-1-00071 3 862 873 879
disease FR940405-1-00071 3 863 874 880
defines FR940405-1-00071 1 871
coronary FR940405-1-00071 1 878
excluding FR940405-1-00071 2 881 922
strokes FR940405-1-00071 1 882
defined FR940405-1-00071 1 885
framingham FR940405-1-00071 1 888
study FR940405-1-00071 1 889
ex FR940405-1-00071 1 891
4108 FR940405-1-00071 1 893
were FR940405-1-00071 1 910
severe FR940405-1-00071 1 919
headaches FR940405-1-00071 1 920
migraines FR940405-1-00071 1 923
respiratory FR940405-1-00071 1 927
conditions FR940405-1-00071 3 928 952 1007
stuffy FR940405-1-00071 1 933
nose FR940405-1-00071 2 934 939
runny FR940405-1-00071 1 938
etc FR940405-1-00071 1 942
aware FR940405-1-00071 1 946
more FR940405-1-00071 1 950
serious FR940405-1-00071 1 951
legionellosis FR940405-1-00071 1 955
hypersensitivity FR940405-1-00071 1 957
diseases FR940405-1-00071 1 958
poor FR940405-1-00071 2 961 1010
suspected FR940405-1-00071 1 965
potential FR940405-1-00071 1 968
hazards FR940405-1-00071 1 970
however FR940405-1-00071 1 972
agency FR940405-1-00071 1 975
currently FR940405-1-00071 1 976
does FR940405-1-00071 1 977
not FR940405-1-00071 1 978
adequate FR940405-1-00071 1 980
conduct FR940405-1-00071 1 983
addressing FR940405-1-00071 1 988
risks FR940405-1-00071 1 990
workplace FR940405-1-00071 2 993 1016
continuing FR940405-1-00071 1 997
develop FR940405-1-00071 1 999
appropriate FR940405-1-00071 1 1000
methodology FR940405-1-00071 1 1001
address FR940405-1-00071 1 1003
estimations FR940405-1-00071 1 1005
related FR940405-1-00071 1 1008
quality FR940405-1-00071 1 1013
requesting FR940405-1-00071 1 1019
input FR940405-1-00071 1 1020
relevant FR940405-1-00071 1 1024
efforts FR940405-1-00071 1 1027
there FR940405-1-00072 1 0
is FR940405-1-00072 2 1 129
uncertainty FR940405-1-00072 2 2 28
associated FR940405-1-00072 2 3 73
with FR940405-1-00072 3 4 74 110
the FR940405-1-00072 11 5 25 42 115 155 205 213 279 282 289 309
quantification FR940405-1-00072 1 6
of FR940405-1-00072 16 7 10 24 27 38 44 53 81 117 183 187 191 209 219 281 292
any FR940405-1-00072 1 8
kind FR940405-1-00072 1 9
risk FR940405-1-00072 9 11 15 39 55 86 94 173 291 311
. FR940405-1-00072 25 12 40 78 114 154 175 195 218 251 275 324 341 351 355 363 373 383 393 399 404 411 418 425 432 439
in FR940405-1-00072 7 13 92 133 150 170 212 295
this FR940405-1-00072 3 14 45 93
assessment FR940405-1-00072 4 16 95 174 186
, FR940405-1-00072 6 17 56 96 221 277 285
osha FR940405-1-00072 9 18 35 57 97 160 184 196 262 286
has FR940405-1-00072 3 19 58 145
tried FR940405-1-00072 1 20
to FR940405-1-00072 16 21 30 76 104 123 127 141 161 201 203 234 256 272 298 301 316
describe FR940405-1-00072 1 22
many FR940405-1-00072 1 23
sources FR940405-1-00072 1 26
and FR940405-1-00072 18 29 47 62 67 84 135 138 178 207 236 239 248 269 306 308 322 371 388
address FR940405-1-00072 1 31
their FR940405-1-00072 1 32
implications FR940405-1-00072 1 33
for FR940405-1-00072 5 34 41 48 168 312
's FR940405-1-00072 3 36 185 263
estimates FR940405-1-00072 2 37 87
purpose FR940405-1-00072 2 43 116
rulemaking FR940405-1-00072 1 46
deriving FR940405-1-00072 1 49
a FR940405-1-00072 9 50 89 119 130 147 171 181 228 242
quantitative FR940405-1-00072 2 51 172
estimate FR940405-1-00072 1 52
occupational FR940405-1-00072 1 54
concentrated FR940405-1-00072 1 59
on FR940405-1-00072 3 60 199 278
information FR940405-1-00072 1 61
data FR940405-1-00072 1 63
concerning FR940405-1-00072 1 64
heart FR940405-1-00072 4 65 136 249 313
disease FR940405-1-00072 4 66 137 250 314
lung FR940405-1-00072 3 68 237 293
cancer FR940405-1-00072 5 69 134 238 294 331
as FR940405-1-00072 2 70 88
potential FR940405-1-00072 2 71 167
effects FR940405-1-00072 3 72 113 153
exposure FR940405-1-00072 9 75 103 126 140 200 233 247 300 318
ets FR940405-1-00072 9 77 105 128 192 202 235 246 302 317
b. FR940405-1-00072 1 79
review FR940405-1-00072 3 80 157 264
epidemiologic FR940405-1-00072 4 82 100 189 268
studies FR940405-1-00072 8 83 101 164 190 198 252 283 327
published FR940405-1-00072 1 85
first FR940405-1-00072 1 90
step FR940405-1-00072 1 91
critically FR940405-1-00072 1 98
reviewed FR940405-1-00072 3 99 284 328
associating FR940405-1-00072 1 102
or FR940405-1-00072 1 106
indoor FR940405-1-00072 2 107 142
air FR940405-1-00072 2 108 143
pollutants FR940405-1-00072 2 109 144
adverse FR940405-1-00072 1 111
health FR940405-1-00072 1 112
such FR940405-1-00072 1 118
critical FR940405-1-00072 2 120 156
evaluation FR940405-1-00072 1 121
was FR940405-1-00072 2 122 223
determine FR940405-1-00072 2 124 204
whether FR940405-1-00072 2 125 139
causal FR940405-1-00072 1 131
factor FR940405-1-00072 1 132
caused FR940405-1-00072 1 146
significant FR940405-1-00072 2 148 243
increase FR940405-1-00072 1 149
acute FR940405-1-00072 1 151
irritant FR940405-1-00072 1 152
also FR940405-1-00072 1 158
enables FR940405-1-00072 1 159
select FR940405-1-00072 1 162
those FR940405-1-00072 2 163 220
that FR940405-1-00072 4 165 225 253 288
have FR940405-1-00072 1 166
use FR940405-1-00072 1 169
tables FR940405-1-00072 1 176
iv1 FR940405-1-00072 1 177
iv2 FR940405-1-00072 1 179
contain FR940405-1-00072 1 180
summary FR940405-1-00072 1 182
several FR940405-1-00072 1 188
exposed FR940405-1-00072 1 193
individuals FR940405-1-00072 1 194
evaluated FR940405-1-00072 1 197
importance FR940405-1-00072 1 206
weight FR940405-1-00072 1 208
each FR940405-1-00072 1 210
study FR940405-1-00072 1 211
overall FR940405-1-00072 2 214 276
hazard FR940405-1-00072 1 215
identification FR940405-1-00072 1 216
process FR940405-1-00072 1 217
it FR940405-1-00072 1 222
determined FR940405-1-00072 2 224 255
fourteen FR940405-1-00072 1 226
showed FR940405-1-00072 2 227 241
statistically FR940405-1-00072 1 229
strong FR940405-1-00072 1 230
association FR940405-1-00072 2 231 244
between FR940405-1-00072 4 232 245 304 320
four FR940405-1-00072 1 240
were FR940405-1-00072 1 254
be FR940405-1-00072 1 257
`` FR940405-1-00072 1 258
positive FR940405-1-00072 3 259 333 335
'' FR940405-1-00072 1 260
by FR940405-1-00072 2 261 329
standards FR940405-1-00072 1 265
met FR940405-1-00072 1 266
standard FR940405-1-00072 1 267
statistical FR940405-1-00072 1 270
criteria FR940405-1-00072 1 271
support FR940405-1-00072 1 273
causation FR940405-1-00072 1 274
basis FR940405-1-00072 1 280
concludes FR940405-1-00072 1 287
relative FR940405-1-00072 2 290 310
nonsmokers FR940405-1-00072 1 296
due FR940405-1-00072 2 297 315
chronic FR940405-1-00072 1 299
ranges FR940405-1-00072 2 303 319
1.20 FR940405-1-00072 1 305
1.50 FR940405-1-00072 1 307
1.24 FR940405-1-00072 1 321
3 FR940405-1-00072 1 323
table FR940405-1-00072 1 325
iv1._epidemiologic FR940405-1-00072 1 326
osha_lung FR940405-1-00072 1 330
1 FR940405-1-00072 1 332
1equivocal FR940405-1-00072 2 334 337
trend FR940405-1-00072 1 336
brownson FR940405-1-00072 2 338 348
et FR940405-1-00072 26 339 346 349 357 361 365 368 375 378 381 385 391 397 402 406 409 413 416 420 423 427 430 434 437 441 444
al FR940405-1-00072 26 340 347 350 358 362 366 369 376 379 382 386 392 398 403 407 410 414 417 421 424 428 431 435 438 442 445
( FR940405-1-00072 2 342 352
1992 FR940405-1-00072 1 343
) FR940405-1-00072 2 344 354
akiba FR940405-1-00072 1 345
1987 FR940405-1-00072 1 353
correa FR940405-1-00072 1 356
butler FR940405-1-00072 1 359
buffler FR940405-1-00072 1 360
fontham FR940405-1-00072 1 364
gao FR940405-1-00072 1 367
chan FR940405-1-00072 1 370
fung FR940405-1-00072 1 372
garfinkel FR940405-1-00072 1 374
gillis FR940405-1-00072 1 377
hole FR940405-1-00072 1 380
geng FR940405-1-00072 1 384
kabat FR940405-1-00072 1 387
wynder FR940405-1-00072 1 389
janerich FR940405-1-00072 1 390
hirayama FR940405-1-00072 1 394
1984a FR940405-1-00072 1 395
katada FR940405-1-00072 1 396
humble FR940405-1-00072 1 400
koo FR940405-1-00072 1 401
inoue FR940405-1-00072 1 405
lee FR940405-1-00072 1 408
kalandidi FR940405-1-00072 1 412
shimizu FR940405-1-00072 1 415
lam FR940405-1-00072 1 419
sobue FR940405-1-00072 1 422
pershagen FR940405-1-00072 1 426
svenson FR940405-1-00072 1 429
sandler FR940405-1-00072 1 433
wu FR940405-1-00072 1 436
stockwell FR940405-1-00072 1 440
trichopoulos FR940405-1-00072 1 443
table FR940405-1-00073 3 0 93 207
iv FR940405-1-00073 3 1 94 208
2._ FR940405-1-00073 1 2
epidemiologic FR940405-1-00073 1 3
studies FR940405-1-00073 7 4 56 160 166 205 269 390
reviewed FR940405-1-00073 1 5
by FR940405-1-00073 3 6 61 337
osha FR940405-1-00073 2 7 76
heart FR940405-1-00073 2 8 214
disease FR940405-1-00073 2 9 215
1positive FR940405-1-00073 1 10
1equivocal FR940405-1-00073 2 11 14
positive FR940405-1-00073 1 12
trend FR940405-1-00073 1 13
dobson FR940405-1-00073 1 15
et FR940405-1-00073 11 16 19 22 28 31 35 38 41 44 108 150
al FR940405-1-00073 11 17 20 23 29 32 36 39 42 45 109 151
gillis FR940405-1-00073 1 18
garland FR940405-1-00073 1 21
. FR940405-1-00073 26 24 33 75 92 110 113 124 136 145 152 155 179 190 203 206 224 232 244 253 255 267 293 334 375 378 416
he FR940405-1-00073 1 25
1989 FR940405-1-00073 1 26
hole FR940405-1-00073 1 27
lee FR940405-1-00073 1 30
helsing FR940405-1-00073 1 34
humble FR940405-1-00073 1 37
sandler FR940405-1-00073 1 40
svendsen FR940405-1-00073 1 43
hirayama FR940405-1-00073 1 46
1964 FR940405-1-00073 1 47
other FR940405-1-00073 2 48 65
relative FR940405-1-00073 3 49 105 219
risk FR940405-1-00073 11 50 83 97 211 220 237 246 258 275 370 386
estimates FR940405-1-00073 4 51 98 212 387
based FR940405-1-00073 2 52 261
on FR940405-1-00073 3 53 57 262
summaries FR940405-1-00073 1 54
of FR940405-1-00073 8 55 80 104 218 296 391 397 405
ets FR940405-1-00073 5 58 266 292 304 326
exposure FR940405-1-00073 10 59 87 243 252 264 290 305 327 350 363
performed FR940405-1-00073 1 60
independent FR940405-1-00073 1 62
scientists FR940405-1-00073 1 63
and FR940405-1-00073 8 64 73 132 141 303 325 356 384
government FR940405-1-00073 1 66
agencies FR940405-1-00073 1 67
are FR940405-1-00073 3 68 260 409
found FR940405-1-00073 1 69
in FR940405-1-00073 7 70 195 276 306 328 340 360
tables FR940405-1-00073 1 71
iv3 FR940405-1-00073 1 72
iv4 FR940405-1-00073 1 74
is FR940405-1-00073 4 77 309 348 367
not FR940405-1-00073 2 78 357
aware FR940405-1-00073 1 79
any FR940405-1-00073 1 81
published FR940405-1-00073 5 82 96 198 210 257
assessments FR940405-1-00073 2 84 259
for FR940405-1-00073 4 85 99 213 286
overall FR940405-1-00073 1 86
to FR940405-1-00073 8 88 238 247 265 291 311 351 411
indoor FR940405-1-00073 1 89
air FR940405-1-00073 1 90
pollutants FR940405-1-00073 1 91
3._ FR940405-1-00073 1 95
lung FR940405-1-00073 2 100 273
cancer FR940405-1-00073 2 101 274
1study FR940405-1-00073 2 102 216
1estimates FR940405-1-00073 2 103 217
risk1 FR940405-1-00073 1 106
daleger FR940405-1-00073 1 107
[ FR940405-1-00073 10 111 122 134 143 153 177 188 222 230 373
ex FR940405-1-00073 10 112 123 135 144 154 178 189 223 231 374
478 FR940405-1-00073 1 114
] FR940405-1-00073 10 115 126 138 147 157 181 192 226 234 377
1.47 FR940405-1-00073 1 116
( FR940405-1-00073 6 117 128 162 168 173 183
.0762.83 FR940405-1-00073 1 118
) FR940405-1-00073 6 119 130 164 170 175 185
nrc FR940405-1-00073 1 120
1986 FR940405-1-00073 1 121
4239 FR940405-1-00073 1 125
1.34 FR940405-1-00073 1 127
1.181.53 FR940405-1-00073 1 129
repace FR940405-1-00073 1 131
lowry FR940405-1-00073 1 133
4263 FR940405-1-00073 1 137
2.4 FR940405-1-00073 1 139
vainio FR940405-1-00073 1 140
partanen FR940405-1-00073 1 142
4312 FR940405-1-00073 1 146
1.251.30 FR940405-1-00073 1 148
wald FR940405-1-00073 1 149
4315 FR940405-1-00073 1 156
: FR940405-1-00073 1 158
casecontrol FR940405-1-00073 1 159
1.27 FR940405-1-00073 1 161
1.051.53 FR940405-1-00073 1 163
prospective FR940405-1-00073 1 165
1.44 FR940405-1-00073 1 167
1.201.72 FR940405-1-00073 1 169
combined FR940405-1-00073 1 171
1.55 FR940405-1-00073 1 172
1.191.54 FR940405-1-00073 1 174
wells FR940405-1-00073 2 176 229
4319 FR940405-1-00073 2 180 233
2.10 FR940405-1-00073 1 182
1.303.20 FR940405-1-00073 1 184
epa FR940405-1-00073 1 186
1992 FR940405-1-00073 1 187
4311 FR940405-1-00073 1 191
21.19 FR940405-1-00073 1 193
1numbers FR940405-1-00073 1 194
parenthesis FR940405-1-00073 1 196
indicate FR940405-1-00073 1 197
95 FR940405-1-00073 1 199
percent FR940405-1-00073 1 200
confidence FR940405-1-00073 1 201
intervals FR940405-1-00073 1 202
2pooled FR940405-1-00073 1 204
4._ FR940405-1-00073 1 209
steenland FR940405-1-00073 1 221
4292 FR940405-1-00073 1 225
11.51 FR940405-1-00073 1 227
21.37 FR940405-1-00073 1 228
31.32 FR940405-1-00073 1 235
1represents FR940405-1-00073 1 236
nonsmoking FR940405-1-00073 5 239 248 277 403 414
men FR940405-1-00073 1 240
with FR940405-1-00073 2 241 250
spousal FR940405-1-00073 4 242 251 263 281
2represents FR940405-1-00073 1 245
women FR940405-1-00073 1 249
3women FR940405-1-00073 1 254
most FR940405-1-00073 1 256
these FR940405-1-00073 3 268 300 322
have FR940405-1-00073 1 270
examined FR940405-1-00073 1 271
the FR940405-1-00073 12 272 287 294 297 307 318 349 358 368 385 392 412
housewives FR940405-1-00073 1 278
, FR940405-1-00073 8 279 344 355 365 380 395 400 408
using FR940405-1-00073 1 280
smoking FR940405-1-00073 2 282 406
as FR940405-1-00073 5 283 315 317 335 402
a FR940405-1-00073 1 284
surrogate FR940405-1-00073 1 285
wife FR940405-1-00073 1 288
's FR940405-1-00073 1 289
size FR940405-1-00073 1 295
association FR940405-1-00073 2 298 319
between FR940405-1-00073 2 299 321
health FR940405-1-00073 3 301 323 381
effects FR940405-1-00073 3 302 324 382
workplace FR940405-1-00073 1 308
expected FR940405-1-00073 1 310
be FR940405-1-00073 1 312
at FR940405-1-00073 1 313
least FR940405-1-00073 1 314
large FR940405-1-00073 1 316
seen FR940405-1-00073 1 320
residential FR940405-1-00073 1 329
settings FR940405-1-00073 1 330
or FR940405-1-00073 2 331 396
public FR940405-1-00073 1 332
places FR940405-1-00073 1 333
noted FR940405-1-00073 1 336
meridian FR940405-1-00073 1 338
research FR940405-1-00073 1 339
their FR940405-1-00073 1 341
1988 FR940405-1-00073 1 342
report FR940405-1-00073 1 343
`` FR940405-1-00073 1 345
... FR940405-1-00073 1 346
it FR940405-1-00073 1 347
environmental FR940405-1-00073 1 352
tobacco FR940405-1-00073 1 353
smoke FR940405-1-00073 1 354
environment FR940405-1-00073 1 359
which FR940405-1-00073 1 361
that FR940405-1-00073 2 362 366
occurs FR940405-1-00073 1 364
important FR940405-1-00073 1 369
factor FR940405-1-00073 1 371
'' FR940405-1-00073 1 372
4221 FR940405-1-00073 1 376
therefore FR940405-1-00073 1 379
observed FR940405-1-00073 1 383
calculated FR940405-1-00073 1 388
from FR940405-1-00073 1 389
general FR940405-1-00073 1 393
population FR940405-1-00073 2 394 415
selected FR940405-1-00073 1 398
subgroups FR940405-1-00073 1 399
such FR940405-1-00073 1 401
wives FR940405-1-00073 1 404
husbands FR940405-1-00073 1 407
relevant FR940405-1-00073 1 410
working FR940405-1-00073 1 413
in FR940405-1-00074 27 0 17 27 37 105 109 128 164 182 190 194 212 232 245 270 330 339 348 380 459 469 511 525 582 797 854 888
developing FR940405-1-00074 2 1 195
risk FR940405-1-00074 7 2 169 189 197 316 346 857
estimates FR940405-1-00074 2 3 170
for FR940405-1-00074 8 4 144 199 280 360 611 626 844
disease FR940405-1-00074 3 5 83 881
attributable FR940405-1-00074 1 6
to FR940405-1-00074 20 7 20 56 177 238 286 324 332 415 457 655 676 774 779 812 836 849 859 862 869
occupational FR940405-1-00074 5 8 32 180 345 860
exposure FR940405-1-00074 26 9 15 57 101 123 129 291 296 378 397 414 424 487 494 509 542 554 557 610 642 652 675 799 816 842 861
, FR940405-1-00074 34 10 26 34 81 84 147 154 168 202 244 248 255 282 292 297 310 329 335 350 362 481 518 548 566 571 598 613 622 631 643 653 750 760 829
reliance FR940405-1-00074 1 11
is FR940405-1-00074 14 12 43 51 67 71 78 96 235 262 284 483 594 604 795
placed FR940405-1-00074 1 13
on FR940405-1-00074 4 14 172 319 807
encountered FR940405-1-00074 1 16
the FR940405-1-00074 47 18 21 28 76 93 98 110 126 138 141 160 188 203 226 288 293 298 301 343 354 374 381 399 429 433 443 449 460 464 470 505 512 546 550 586 589 602 605 644 659 785 798 804 808 813 871 889
workplace FR940405-1-00074 15 19 357 382 389 461 486 513 547 556 603 645 695 715 777 805
extent FR940405-1-00074 1 22
possible FR940405-1-00074 1 23
. FR940405-1-00074 41 24 46 69 92 112 166 193 217 220 242 260 279 308 347 359 366 369 383 398 425 435 462 495 532 577 585 596 620 671 735 738 744 747 754 757 765 768 781 822 864 895
however FR940405-1-00074 4 25 243 309 549
absence FR940405-1-00074 1 29
of FR940405-1-00074 28 30 64 74 100 122 140 228 240 290 295 342 356 376 395 408 413 428 438 448 492 507 588 608 641 651 784 792 874
purely FR940405-1-00074 1 31
data FR940405-1-00074 4 33 787 824 850
information FR940405-1-00074 2 35 114
derived FR940405-1-00074 1 36
environments FR940405-1-00074 2 38 214
other FR940405-1-00074 8 39 111 304 351 526 572 705 725
than FR940405-1-00074 4 40 108 159 545
work FR940405-1-00074 5 41 400 416 479 562
sites FR940405-1-00074 3 42 401 417
also FR940405-1-00074 2 44 771
considered FR940405-1-00074 1 45
osha FR940405-1-00074 2 47 846
believes FR940405-1-00074 1 48
that FR940405-1-00074 15 49 97 125 225 239 264 315 373 485 504 601 625 656 803 832
there FR940405-1-00074 2 50 265
no FR940405-1-00074 1 52
physiological FR940405-1-00074 1 53
difference FR940405-1-00074 3 54 95 551
related FR940405-1-00074 2 55 88
( FR940405-1-00074 16 58 445 514 520 528 561 664 683 697 702 707 717 722 727 788 882
or FR940405-1-00074 3 59 85 524
its FR940405-1-00074 2 60 196
outcome FR940405-1-00074 1 61
) FR940405-1-00074 16 62 452 517 523 531 576 670 685 699 704 709 719 724 729 801 885
regardless FR940405-1-00074 2 63 73
where FR940405-1-00074 1 65
it FR940405-1-00074 6 66 261 283 482 599 623
experienced FR940405-1-00074 3 68 657 817
this FR940405-1-00074 3 70 592 793
true FR940405-1-00074 3 72 263 344
whether FR940405-1-00074 1 75
endpoint FR940405-1-00074 1 77
lung FR940405-1-00074 3 79 200 893
cancer FR940405-1-00074 3 80 201 894
heart FR940405-1-00074 2 82 880
indoor FR940405-1-00074 1 86
air FR940405-1-00074 1 87
acute FR940405-1-00074 1 89
irritant FR940405-1-00074 1 90
effects FR940405-1-00074 1 91
only FR940405-1-00074 2 94 830
degree FR940405-1-00074 1 99
may FR940405-1-00074 2 102 336
be FR940405-1-00074 4 103 837 852 867
greater FR940405-1-00074 1 104
one FR940405-1-00074 1 106
place FR940405-1-00074 1 107
available FR940405-1-00074 1 113
which FR940405-1-00074 4 115 208 273 845
uses FR940405-1-00074 1 116
nicotine FR940405-1-00074 3 117 210 230
concentration FR940405-1-00074 1 118
as FR940405-1-00074 8 119 149 250 306 326 826 870 886
an FR940405-1-00074 2 120 340
index FR940405-1-00074 1 121
suggests FR940405-1-00074 2 124 314
differences FR940405-1-00074 1 127
between FR940405-1-00074 2 130 552
office FR940405-1-00074 2 131 233
workplaces FR940405-1-00074 8 132 146 184 192 234 247 325 334
and FR940405-1-00074 15 133 143 151 185 252 303 328 410 422 478 555 761 843 877 892
residences FR940405-1-00074 2 134 165
lie FR940405-1-00074 1 135
well FR940405-1-00074 3 136 307 327
within FR940405-1-00074 1 137
uncertainties FR940405-1-00074 1 139
determinations FR940405-1-00074 2 142 272
some FR940405-1-00074 4 145 191 246 333
such FR940405-1-00074 3 148 249 271
restaurants FR940405-1-00074 2 150 251
transportation FR940405-1-00074 2 152 253
facilities FR940405-1-00074 2 153 254
exposures FR940405-1-00074 8 155 162 174 256 321 358 480 778
are FR940405-1-00074 6 156 175 257 266 322 580
significantly FR940405-1-00074 3 157 258 838
higher FR940405-1-00074 2 158 259
average FR940405-1-00074 3 161 229 809
found FR940405-1-00074 3 163 372 796
thus FR940405-1-00074 1 167
based FR940405-1-00074 2 171 318
residential FR940405-1-00074 1 173
expected FR940405-1-00074 1 176
accurately FR940405-1-00074 1 178
reflect FR940405-1-00074 1 179
risks FR940405-1-00074 1 181
most FR940405-1-00074 2 183 465
possibly FR940405-1-00074 1 186
underestimate FR940405-1-00074 2 187 341
assessment FR940405-1-00074 1 198
epa FR940405-1-00074 3 204 221 311
reviewed FR940405-1-00074 1 205
19 FR940405-1-00074 1 206
studies FR940405-1-00074 2 207 352
investigated FR940405-1-00074 1 209
concentrations FR940405-1-00074 2 211 231
various FR940405-1-00074 1 213
[ FR940405-1-00074 6 215 367 736 745 755 766
ex FR940405-1-00074 5 216 368 737 756 767
4311 FR940405-1-00074 1 218
] FR940405-1-00074 6 219 371 740 749 759 770
's FR940405-1-00074 2 222 312
analysis FR940405-1-00074 2 223 313
showed FR940405-1-00074 1 224
range FR940405-1-00074 2 227 394
very FR940405-1-00074 1 236
similar FR940405-1-00074 1 237
homes FR940405-1-00074 1 241
many FR940405-1-00074 1 267
complicating FR940405-1-00074 1 268
factors FR940405-1-00074 2 269 305
could FR940405-1-00074 1 274
affect FR940405-1-00074 1 275
any FR940405-1-00074 1 276
final FR940405-1-00074 1 277
conclusions FR940405-1-00074 1 278
example FR940405-1-00074 2 281 361
important FR940405-1-00074 1 285
consider FR940405-1-00074 1 287
duration FR940405-1-00074 1 289
intensity FR940405-1-00074 1 294
distance FR940405-1-00074 1 299
from FR940405-1-00074 4 300 388 403 591
sources FR940405-1-00074 2 302 825
assessments FR940405-1-00074 1 317
home FR940405-1-00074 10 320 434 444 477 519 544 553 567 700 720
relevant FR940405-1-00074 1 323
comparison FR940405-1-00074 1 331
even FR940405-1-00074 2 337 632
result FR940405-1-00074 1 338
addition FR940405-1-00074 1 349
substantiate FR940405-1-00074 1 353
magnitude FR940405-1-00074 1 355
emmons FR940405-1-00074 2 363 732
et FR940405-1-00074 5 364 733 742 752 763
al FR940405-1-00074 5 365 734 743 753 764
498 FR940405-1-00074 2 370 739
majority FR940405-1-00074 2 375 506
ets FR940405-1-00074 8 377 396 609 677 780 815 841 863
occurred FR940405-1-00074 1 379
study FR940405-1-00074 5 384 471 593 794 891
subjects FR940405-1-00074 4 385 430 496 533
were FR940405-1-00074 2 386 472
selected FR940405-1-00074 1 387
settings FR940405-1-00074 1 390
with FR940405-1-00074 10 391 405 418 501 536 618 629 662 691 840
a FR940405-1-00074 8 392 489 648 692 712 782 789 819
wide FR940405-1-00074 1 393
ranged FR940405-1-00074 1 402
those FR940405-1-00074 3 404 439 473
minimal FR940405-1-00074 1 406
restriction FR940405-1-00074 1 407
smoking FR940405-1-00074 3 409 420 458
high FR940405-1-00074 1 411
levels FR940405-1-00074 1 412
extensive FR940405-1-00074 1 419
restrictions FR940405-1-00074 1 421
low FR940405-1-00074 1 423
ninety FR940405-1-00074 1 426
percent FR940405-1-00074 4 427 437 687 811
worked FR940405-1-00074 2 431 441
outside FR940405-1-00074 2 432 442
eightyfour FR940405-1-00074 1 436
who FR940405-1-00074 5 440 474 497 534 614
75.6 FR940405-1-00074 1 446
% FR940405-1-00074 1 447
total FR940405-1-00074 2 450 814
sample FR940405-1-00074 1 451
reported FR940405-1-00074 4 453 503 538 835
being FR940405-1-00074 1 454
regularly FR940405-1-00074 1 455
exposed FR940405-1-00074 2 456 467
while FR940405-1-00074 1 463
highly FR940405-1-00074 1 466
individuals FR940405-1-00074 1 468
had FR940405-1-00074 1 475
both FR940405-1-00074 1 476
clear FR940405-1-00074 1 484
constituted FR940405-1-00074 1 488
significant FR940405-1-00074 2 490 776
component FR940405-1-00074 1 491
overall FR940405-1-00074 1 493
did FR940405-1-00074 1 498
not FR940405-1-00074 3 499 559 616
live FR940405-1-00074 2 500 617
smokers FR940405-1-00074 4 502 537 619 630
their FR940405-1-00074 3 508 634 638
was FR940405-1-00074 2 510 558
mean=36.1 FR940405-1-00074 1 515
min/day FR940405-1-00074 9 516 522 530 565 570 575 666 669 684
mean=1.4 FR940405-1-00074 1 521
locations FR940405-1-00074 1 527
mean=13.1 FR940405-1-00074 1 529
lived FR940405-1-00074 1 535
receiving FR940405-1-00074 1 539
slightly FR940405-1-00074 1 540
more FR940405-1-00074 1 541
at FR940405-1-00074 1 543
substantial FR940405-1-00074 2 560 649
: FR940405-1-00074 6 563 568 573 694 714 731
mean=29.4 FR940405-1-00074 1 564
mean=31.2 FR940405-1-00074 1 569
mean=27.1 FR940405-1-00074 1 574
these FR940405-1-00074 2 578 865
results FR940405-1-00074 2 579 773
shown FR940405-1-00074 1 581
table FR940405-1-00074 2 583 672
iv5 FR940405-1-00074 1 584
importance FR940405-1-00074 1 587
findings FR940405-1-00074 1 590
twofold FR940405-1-00074 1 595
first FR940405-1-00074 1 597
indicates FR940405-1-00074 1 600
primary FR940405-1-00074 2 606 639
source FR940405-1-00074 2 607 640
nonsmokers FR940405-1-00074 3 612 627 663
do FR940405-1-00074 1 615
secondly FR940405-1-00074 1 621
shows FR940405-1-00074 2 624 802
living FR940405-1-00074 4 628 661 690 710
though FR940405-1-00074 1 633
household FR940405-1-00074 1 635
environment FR940405-1-00074 1 636
becomes FR940405-1-00074 1 637
still FR940405-1-00074 1 646
contributes FR940405-1-00074 2 647 806
amount FR940405-1-00074 1 650
comparable FR940405-1-00074 1 654
by FR940405-1-00074 3 658 678 818
nonsmoker FR940405-1-00074 1 660
29.4 FR940405-1-00074 2 665 696
v. FR940405-1-00074 1 667
36.1 FR940405-1-00074 2 668 716
iv FR940405-1-00074 1 673
5._ FR940405-1-00074 1 674
location1 FR940405-1-00074 1 679
1subject FR940405-1-00074 1 680
category FR940405-1-00074 1 681
1exposure FR940405-1-00074 1 682
195 FR940405-1-00074 1 686
confidence FR940405-1-00074 1 688
interval FR940405-1-00074 1 689
smoker FR940405-1-00074 2 693 713
7.0151.80 FR940405-1-00074 1 698
31.2 FR940405-1-00074 1 701
21.6040.80 FR940405-1-00074 1 703
27.1 FR940405-1-00074 1 706
15.1039.10 FR940405-1-00074 1 708
without FR940405-1-00074 1 711
22.7049.50 FR940405-1-00074 1 718
1.4 FR940405-1-00074 1 721
0.052.75 FR940405-1-00074 1 723
13.1 FR940405-1-00074 1 726
8.7517.40 FR940405-1-00074 1 728
1source FR940405-1-00074 1 730
cummings FR940405-1-00074 1 741
exs FR940405-1-00074 1 746
467 FR940405-1-00074 1 748
hudgafvelpursiainen FR940405-1-00074 1 751
4152 FR940405-1-00074 1 758
marcus FR940405-1-00074 1 762
4205 FR940405-1-00074 1 769
present FR940405-1-00074 1 772
show FR940405-1-00074 1 775
res FR940405-1-00074 1 783
caps FR940405-1-00074 1 786
detailed FR940405-1-00074 1 790
description FR940405-1-00074 1 791
section FR940405-1-00074 1 800
46 FR940405-1-00074 1 810
nonsmoking FR940405-1-00074 1 820
worker FR940405-1-00074 1 821
c. FR940405-1-00074 1 823
mentioned FR940405-1-00074 1 827
previously FR940405-1-00074 1 828
diseases FR940405-1-00074 2 831 873
have FR940405-1-00074 1 833
been FR940405-1-00074 1 834
associated FR940405-1-00074 1 839
has FR940405-1-00074 1 847
access FR940405-1-00074 1 848
will FR940405-1-00074 2 851 866
used FR940405-1-00074 1 853
calculating FR940405-1-00074 1 855
health FR940405-1-00074 1 856
due FR940405-1-00074 1 858
referred FR940405-1-00074 1 868
`` FR940405-1-00074 1 872
interest FR940405-1-00074 1 875
'' FR940405-1-00074 1 876
include FR940405-1-00074 1 878
coronary FR940405-1-00074 1 879
excluding FR940405-1-00074 1 883
strokes FR940405-1-00074 1 884
defined FR940405-1-00074 1 887
framingham FR940405-1-00074 1 890
ideally FR940405-1-00075 1 0
, FR940405-1-00075 1 1
data FR940405-1-00075 1 2
on FR940405-1-00075 1 3
the FR940405-1-00075 4 4 7 12 19
incidence FR940405-1-00075 1 5
of FR940405-1-00075 4 6 9 21 23
diseases FR940405-1-00075 1 8
interest FR940405-1-00075 1 10
in FR940405-1-00075 2 11 25
us FR940405-1-00075 1 13
population FR940405-1-00075 1 14
were FR940405-1-00075 1 15
needed FR940405-1-00075 1 16
to FR940405-1-00075 1 17
estimate FR940405-1-00075 1 18
number FR940405-1-00075 1 20
cases FR940405-1-00075 1 22
disease FR940405-1-00075 1 24
employed FR940405-1-00075 1 26
nonsmokers FR940405-1-00075 1 27
. FR940405-1-00075 1 28
since FR940405-1-00075 1 29
nationwide FR940405-1-00075 1 30
